Dietary Supplementation with Ferula Improves Productive Performance, Serum Levels of Reproductive Hormones, and Reproductive Gene Expression in Aged Laying Hens

This study investigated the effects of dietary Ferula supplementation on productive performance, egg quality, follicular development, serum levels of reproductive hormones, and reproductive gene expression in aged laying hens. A total of 300 Dawu pink laying hens (65 weeks old) were assigned to four treatments with six replicates per treatment and 10 hens per replicate. The birds were individually housed in wire cages and fed a corn-soybean meal-based diet with added Ferula at doses of 0, 50, 100, and 200 mg/kg for 12 weeks. The results showed that the laying rate in the 100 mg/kg Ferula-supplemented group was higher than in birds of the control group during weeks 1 to 12 (p<0.05). The average egg weight in the 100 mg/kg Ferula-supplemented group was significantly higher than in the other groups (p<0.01), while the feed-to-egg ratio was significantly lower than in other groups (p<0.01). The numbers of small yellow follicle, middle white follicle, and small white follicle were higher in the 100 mg/kg Ferula-supplemented birds than in the other groups (p<0.01). On weeks 69, the serum levels of estradiol, follicle-stimulating hormone, and luteinizing hormone were significantly higher in the 100 mg/kg Ferula-supplemented group than in the other groups (p<0.05). Additionally, expressions of ERα, FSHR, and LHR in the ovarian tissue were up-regulated by Ferula supplementation, especially in the 100 mg/kg group (p<0.01). These results indicate that the Ferula supplementation can significantly improve productive performance, egg quality, reproduction of hormonal profile, and reproductive gene expression of aged laying hens.

Dietary Supplementation with Ferula Improves Productive Performance, Serum Levels of Reproductive Hormones, and Reproductive Gene Expression in Aged Laying Hens

This study investigated the effects of dietary Ferula supplementation on productive performance, egg quality, follicular development, serum levels of reproductive hormones, and reproductive gene expression in aged laying hens. A total of 300 Dawu pink laying hens (65 weeks old) were assigned to four treatments with six replicates per treatment and 10 hens per replicate. The birds were individually housed in wire cages and fed a corn-soybean meal-based diet with added Ferula at doses of 0, 50, 100, and 200 mg/kg for 12 weeks. The results showed that the laying rate in the 100 mg/kg Ferula-supplemented group was higher than in birds of the control group during weeks 1 to 12 (p<0.05). The average egg weight in the 100 mg/kg Ferula-supplemented group was significantly higher than in the other groups (p<0.01), while the feed-to-egg ratio was significantly lower than in other groups (p<0.01). The numbers of small yellow follicle, middle white follicle, and small white follicle were higher in the 100 mg/kg Ferula-supplemented birds than in the other groups (p<0.01). On weeks 69, the serum levels of estradiol, follicle-stimulating hormone, and luteinizing hormone were significantly higher in the 100 mg/kg Ferula-supplemented group than in the other groups (p<0.05). Additionally, expressions of ERα, FSHR, and LHR in the ovarian tissue were up-regulated by Ferula supplementation, especially in the 100 mg/kg group (p<0.01). These results indicate that the Ferula supplementation can significantly improve productive performance, egg quality, reproduction of hormonal profile, and reproductive gene expression of aged laying hens.(AU)

Distinct non-cerebrovascular risk factors for ischemic lacunar stroke and non-lacunar stroke: preliminary results.

Stroke is a non-communicable disease of increasing socioeconomic importance in aging populations. This study compared the risk factors implicated in two subtypes of ischemic stroke: lacunar stroke (LS) and non-lacunar stroke (NLS). A retrospective case control study was conducted on a total of 368 patients [220 cases (59.8%) of NLS and 148 cases (40.2%) of LS] with first-time onset of ischemic stroke. Multivariate logistic regression was performed to compare multiple non-cerebrovascular risk factors between the two groups. More patients with a history of diabetes were found in the NLS than the LS group (40.5 vs 26.4%), and that both fasting glucose and HbA1C levels before the onset of stroke were higher in NLS than LS patients. Multivariate analysis revealed that patients with a history of diabetes were 1.57 times more likely to have NLS than LS (OR = 1.57, 95%CI = 0.95-3.26). Moreover, male patients were more likely to develop NLS than females (OR = 1.46, 95%CI = 0.79-2.69), and patients with elevated fibrinogen levels were 1.4 times more likely to develop NLS than LS (OR = 1.40, 95%CI = 1.09-1.80). Additionally, patients who were heavy drinkers (OR = 1.39, 95%CI = 0.68-2.84) or smokers (OR = 1.62, 95%CI = 0.91-2.89) were more likely to develop NLS than LS. Other risk factors, such as hypertension, dyslipidemia, age, and average blood pressure, did not differ between the two types of stroke. Thus, distinct non-cerebrovascular risk factors (male gender, long history of diabetes, elevated fibrinogen, heavy smoking, and heavy drinking) are associated with a higher risk of developing non-lacunar stroke than lacunar stroke.

Expression divergence of FRUITFULL homeologs enhanced pod shatter resistance in Brassica napus.

To improve pod shatter resistance in the important oilseed crop Brassica napus, the phenotypic diversity of B. napus was tested using 80 B. napus varieties for pod shatter resistance by a random impact test. Among these varieties, R1-1 was identified as resistant, while R2, 8908B was susceptible to shatter. To understand the molecular basis for this phenotypic difference based on the candidate gene approach, B. napus FRUITFULL (FUL) homologs were identified and characterized. Two FUL loci in the A and C genomes of B. napus were identified. In the susceptible variety, both BnaA.FUL and BnaC.FUL were expressed in the same tissues. However, the expression level of BnaC.FUL differed in varieties with different pod shatter resistance. In the most resistant variety, R1-1, only BnaA.FUL was expressed, while BnaC.FUL was silenced. Therefore, the functional divergence and differing expression of BnaX.FUL homeologs may significantly affect phenotypic variation, which is an important consequence of allopolyploid evolution. This expression level divergence may be useful for selecting pod shatter resistant lines through marker-assisted selection in B. napus-breeding programs.

Overexpression of the cytochrome P450 monooxygenase (cyp71av1) and cytochrome P450 reductase (cpr) genes increased artemisinin content in Artemisia annua (Asteraceae).

Finding an efficient and affordable treatment against malaria is still a challenge for medicine. Artemisinin is an effective anti-malarial drug isolated from Artemisia annua. However, the artemisinin content of A. annua is very low. We used transgenic technology to increase the artemisinin content of A. annua by overexpressing cytochrome P450 monooxygenase (cyp71av1) and cytochrome P450 reductase (cpr) genes. CYP71AV1 is a key enzyme in the artemisinin biosynthesis pathway, while CPR is a redox partner for CYP71AV1. Eight independent transgenic A. annua plants were obtained through Agrobacterium tumefaciens-mediated transformation, which was confirmed by PCR and Southern blot analyses. The real-time qPCR results showed that the gene cyp71av1 was highly expressed at the transcriptional level in the transgenic A. annua plants. HPLC analysis showed that the artemisinin content was increased in a number of the transgenic plants, in which both cyp71av1 and cpr were overexpressed. In one of the transgenic A. annua plants, the artemisinin content was 38% higher than in the non-transgenic plants. We conclude that overexpressing key enzymes of the biosynthesis pathway is an effective means for increasing artemisinin content in plants.